February 25, 2010 Dallasnews.com: The Dallas Morning News NewCo will help bring cost effective advanced technology to North Texas. Laboratory tests which had to be sent out of state can be handled locally which means faster results for patients.
February 2010 Specialty Pharmacy News Genomics tests that provide clearer treatment alternatives will become more commonplace in the future. “We will add a lot of new tests focused on oncology that will bring more clarity in terms of treatment options” CEO Laughman said.
January 27, 2010 Genomweb A joint venture in the Dallas area will focus on cancer and offer clinical laboratory services, molecular diagnostics and pharmacogenomic tests.
January 26, 2010 FierceBiotech U.S. Oncology and Baylor Health Care System have formed a joint venture to explore the development of new, personalized cancer therapies targeted at specific genes.
January 22-28th, 2010 Dallas Business Journal A laboratory testing and molecular diagnostics facility affiliated with the Baylor Health Care System has selected a location in Lewisville where it plans to employ 900+. NewCo, whose mission is to improve patient care by providing personalized diagnostics, says branding efforts are underway and the company will change its [...]
January 22, 2010 Sacramento Business Journal NewCo, a joint venture between the Baylor Health Care System and US Oncology and other possible partners has leased 172,000 square feet in Lewisville, Texas and plans to employ more than 900 people. The company’s mission is to improve patient care by providing personalized medical diagnostics including molecular diagnostics.
October 9, 2009 Dallas Business Journal “NewCo” is a newly formed venture between Baylor Health Care System and an unidentified entity.